Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
-
Busy address KBO
14 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
Associatie Nefrologie-Endocrinologie from Turnhout, company number BE0459742485, closed financial year 2025 with a result of € -6,491 after tax. For that financial year Associatie Nefrologie-Endocrinologie recorded a gross margin of € -5,222 and equity of € 20,949. Compared with financial year 2024, the result moved from € -1,755 to € -6,491. The company made a loss. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 22, 2026.
€ 20,949
▼ 24% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -6,491
▼ 270 % more loss than in 2024
Profit after tax over the fiscal year.
€ 80,806
▼ 43% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € 2,357.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 46,733
▼ 35% vs 2024
Supplier invoices still open on the last day of the fiscal year.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 408 | € 1,266 | € -520 | € -5,222 | ▼ € 4,702 |
| Profit after taxes | € -192 | € 46 | € -1,755 | € -6,491 | ▼ € 4,736 |
| Equity | € 29,149 | € 29,195 | € 27,440 | € 20,949 | ▼ 24% |
| Total debts | € 1,298,103 | € 1,510,851 | € 1,133,986 | € 1,099,320 | ▼ 3% |
| Cash | € 317,813 | € 600,832 | € 141,672 | € 80,806 | ▼ 43% |
| Retained profit | € 10,557 | € 10,603 | € 8,848 | € 2,357 | ▼ 73% |
| Balance sheet total | € 1,327,252 | € 1,540,046 | € 1,161,426 | € 1,120,269 | ▼ 4% |
Key figures of Associatie Nefrologie-Endocrinologie, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Associatie Nefrologie-Endocrinologie?
What happened at Associatie Nefrologie-Endocrinologie in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 6,491. Source: NBB ↗
- Dokters K. Schurmans-H. de Jonge BV became a director. NBB
- Dr. Miranda Zeegers BV became a director. NBB
- New establishment in Turnhout. KBO
- Start of the company according to the CBE. KBO
In short
From € 192 loss in 2022 to € 6,491 loss in 2025.
Best year ever: 2023, with € 46 profit.
A new publication or filing at Associatie Nefrologie-Endocrinologie? We notify you, reason included.
Follow Associatie Nefrologie-EndocrinologieDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of Dr. Veerle Verjans, Endoline comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
Associatie Nefrologie-EndocrinologieBehind Associatie Nefrologie-Endocrinologie are Dokters K. Schurmans-H. de Jonge BV and Dr. Miranda Zeegers BV. The shares are held by Dr. Veerle Verjans (11.2%) and Endoline (11.1%).
Directors
According to the 2025 annual accounts
Dokters K. Schurmans-H. de Jonge BV
Director · represented by Hylke de Jonge
since 2024
Director · represented by Miranda Zeegers
since 2024
Shareholders
11.2%
11.1%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Steenweg op Merksplas 44
2300 Turnhout
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 14 companies are registered at this address.
All companies at this address →KOEKOEKSHOF
€ 17,860 revenue · 2024
Ziekenhuisnetwerk Kempen
Gynesis
NKO/Gezichts- en Gelaatsheelkunde Turnhout
Associatie Orthopedische heelkunde AZ Turnhout
+9 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0459.742.485
- VAT number
- BE 0459.742.485
- Registered office
- Steenweg op Merksplas 44, 2300 Turnhout
- Names & denominations
- Associatie Nefrologie-Endocrinologie
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 8 January 1997
- Peppol
- Active · Active since 9 Dec 2025